ARQT
Arcutis Biotherapeutics, Inc. · Healthcare
Insider Patrick Burnett sold $395K of Arcutis Biotherapeutics, Inc.
Sold$394,897
$26.33Price
15,000Shares
−11%Stake
What ARQT did after the filing
- The stock from Fri, Aug 14 open, $25.39
- +5.4%
- S&P 500, same days
- −1.8%
Measured over 30 trading days, to the Sep 29 close.
Traded Tue, Aug 11. Filed Thu, Aug 13, 8:06 PM ET, after the close. Returns use the Aug 14 open and the Sep 29 close. Not investment advice.